Skip to content
★ Sign in to follow
DA

Daniel A. Hoffman

Executive
Emmaus Life Sciences, Inc.
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€620
▼ Sales (0 ops.)
—

Latest filing published 03 Mar 2009 for Emmaus Life Sciences, Inc., €314.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
67%
Median T+90
+20.0%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Daniel A. Hoffman: trading record in brief

Daniel A. Hoffman is a declared insider of Emmaus Life Sciences, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 20 February 2009 and the latest from 2 March 2009.

No open-market sale appears; the market trades are 3 purchases worth €620. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Half of the purchases are above €291 and half below. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +20.0%. This is a record of the past, not a forecast.

The newest entry dates from 3 March 2009: an open-market purchase of €314, in Emmaus Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel A. Hoffman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations